ConductScience.org, home

Paper37097366

Randomized Trials vs Real-world Evidence: How Can Both Inform Decision-making?

Sheldrick RC. JAMA, 2023. Cited by 78 papers, by iCite.

Cite this record

ConductScience Library. Randomized Trials vs Real-world Evidence: How Can Both Inform Decision-making? Papers, record 37097366. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/37097366

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Randomized Trials vs Real-world Evidence: How Can Both Inform Decision-making?
PubMed
Journal
JAMA
PubMed
Year
2023
PubMed
Publication types
Editorial, Comment
PubMed
Citations, by iCite
78
iCite
Relative citation ratio, by iCite
9.54
iCite
Revised in PubMed
2025-03-31
PubMed

Authors1

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Sheldrick RCR Christopher

Source PubMed

Download CSV of authors

Topics4

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Decision MakingMajor topic
Randomized Controlled Trials as TopicMajor topic
Life Change Events
Research Design

Comments and corrections1

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

KindPMIDTitleIn Papers
Comment on37097356Emulation of Randomized Clinical Trials With Nonrandomized Database Analyses: Results of 32 Clinical Trials.https://conductscience.org/library/papers/37097356

Source PubMed

Download CSV of comments and corrections

Cited by48

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 78 citations.

PMIDTitleJournalYearIn PapersSource
42633174Real-World Clinical Efficacy of Food and Drug Administration-Approved Budesonide Oral Suspension Across Histologic, Endoscopic, and Symptomatic Outcomes.Gastro Hep Adv2026https://conductscience.org/library/papers/42633174PubMed
42548438Using Real-World Research to Study the Impact of Chronic Daily Therapy Discontinuation in Cystic Fibrosis: The Home-Reported Outcomes in Cystic Fibrosis 2 Study Design.CHEST Pulm2024https://conductscience.org/library/papers/42548438PubMed
42499182Defining the Efficacy of Meningococcal B Vaccines Against Gonococcal Acquisition: The Current Landscape.J Int AIDS Soc2026https://conductscience.org/library/papers/42499182PubMed
42443777A stakeholder-inclusive conceptual framework for modeling routinely collected health data for therapeutic decision-making illustrated by means of multistate models.BMC Med Res Methodol2026https://conductscience.org/library/papers/42443777PubMed
42389740Lipid-lowering therapy omission at discharge and one-year outcomes after percutaneous coronary intervention: a real-world analysis of overall and elderly patients.Int J Cardiol Heart Vasc2026https://conductscience.org/library/papers/42389740PubMed
42387883Preoperative physiotherapy and one-year patient-reported outcomes after primary total knee arthroplasty: a registry-based cohort study of 1,688 patients.J Rehabil Med2026https://conductscience.org/library/papers/42387883PubMed
42132959Spironolactone and clinical outcomes in patients with alcohol use disorder and comorbid hypertension: a target trial emulation study.Psychopharmacology (Berl)2026https://conductscience.org/library/papers/42132959PubMed
42127972Real-world effectiveness of thrombectomy for basilar artery occlusion: lessons beyond the ATTENTION and BAOCHE trials.Eur Stroke J2026https://conductscience.org/library/papers/42127972PubMed
42012779Interleukin-23 Inhibitors in Inflammatory Bowel Disease.BioDrugs2026https://conductscience.org/library/papers/42012779PubMed
41953701
Real-world glycemic control, exploratory cardiorenal indicators, and safety of polyethylene glycol loxenatide versus semaglutide in type 2 diabetes patients: a Chinese two-center retrospective cohort study.
Front Endocrinol (Lausanne)2026https://conductscience.org/library/papers/41953701PubMed
41810148Target trial emulation in oncology: current use and future directions.Mil Med Res2025https://conductscience.org/library/papers/41810148PubMed
41646264Early bevacizumab dose and time modifications may affect efficacy of atezolizumab plus bevacizumab for advanced hepatocellular carcinoma treatment.ESMO Gastrointest Oncol2025https://conductscience.org/library/papers/41646264PubMed
41620660Responders and super-responders to atogepant after 24 weeks of treatment in migraine: real-world evidence from the GIANT-2 study.J Headache Pain2026https://conductscience.org/library/papers/41620660PubMed
40956583Integrated Behavioral Health Services and Psychosocial Symptoms in Children.JAMA Netw Open2025https://conductscience.org/library/papers/40956583PubMed
40899334What we cannot miss in clinical trials on compression therapy.Phlebology2026https://conductscience.org/library/papers/40899334PubMed
40817421Age and Sex Differences in Adverse Events Associated With Antipsychotics: An Analysis of the FDA Adverse Events Database.Int J Geriatr Psychiatry2025https://conductscience.org/library/papers/40817421PubMed
40725552Why High-Volume Post-Dilution Hemodiafiltration Should Be the New Standard in Dialysis Care: A Comprehensive Review of Clinical Outcomes and Mechanisms.J Clin Med2025https://conductscience.org/library/papers/40725552PubMed
40600300Real-World Use of Phentermine and Topiramate for Adolescent Obesity: Retrospective Effectiveness and Safety Analysis.Child Obes2025https://conductscience.org/library/papers/40600300PubMed
40548174Clinical Utility of Long-Acting Injectable Risperidone in Schizophrenia and Bipolar I Disorder: A Review of Clinical Studies.Psychol Res Behav Manag2025https://conductscience.org/library/papers/40548174PubMed
40529115Faricimab Outcomes in Chorioretinal Disorders: Indian Real-World Analysis (FOCUS Study).Clin Ophthalmol2025https://conductscience.org/library/papers/40529115PubMed

See all 48 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/37097366

GET https://conductscience.org/api/papers/v1/37097366/cited_by?page=2